Search
2-(5-fluoro-pentyl)-2-methyl-malonic-acid
go.drugbank.com/drugs/DB16029Investigational2-(5-fluoro-pentyl)-2-methyl-malonic-acid is under investigation in clinical trial NCT00696943 (18F ML-10 for Early Detection of Response of Brain Metastases to SRS).
Fonadelpar
go.drugbank.com/drugs/DB16169InvestigationalFonadelpar is under investigation in clinical trial NCT03527212 (A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease).
Visugromab
go.drugbank.com/drugs/DB18894InvestigationalVisugromab is under investigation in clinical trial NCT06059547 (Neoadjuvant Immunotherapy in Combination With the Anti-gdf-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer
Befunolol
go.drugbank.com/drugs/DB09013ExperimentalIt is currently in experimental status, and is being tested for the management of open angle glaucoma.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesVH3739937
go.drugbank.com/drugs/DB25287InvestigationalVH3739937 is under investigation in clinical trial NCT06533280 (VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect
LY-2183240
go.drugbank.com/drugs/DB17035ExperimentalLY-2183240 is an inhibitor of endocannabinoid reuptake/breakdown.[A253037]
Tamrintamab pamozirine
go.drugbank.com/drugs/DB17222InvestigationalTamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
UX053
go.drugbank.com/drugs/DB18558InvestigationalUX053 is an mRNA encoding the human glycogen debranching enzyme.
R-95845
go.drugbank.com/drugs/DB07327ExperimentalR-95845 is an inhibitor of HIV-1 reverse transcriptase.